Myovant Sciences (MYOV) News Today → Did You Get Your Free Bitcoin Yet? (From Crypto Swap Profits) (Ad) Free MYOV Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineGynecology Collaboration, R&D, and Licensing Deals Trends Report 2024finance.yahoo.com - May 7 at 7:42 PMWorld Metastatic Prostate Cancer Drug Landscape Research Report 2024: Comprehensive Insights about 90+ Companies and 110+ Pipeline Drugsuk.finance.yahoo.com - April 18 at 9:20 AM2024 Could Be Women’s Health’s Long-Awaited, Much-Needed Standout Yearforbes.com - January 15 at 2:17 PMGlobal $67B+ Women's Health Market Landscape 2024-2030: Analysis by Age, Application and Regionfinance.yahoo.com - January 11 at 8:54 PMReAlta Life Sciences Strengthens Board of Directors with Appointment of Three Accomplished Biotechnology Executivesfinance.yahoo.com - January 3 at 9:54 AMVivek Ramaswamy wins legal battle over bid to force him to give evidence in multi-million dollar court case after GOP long-shot candidate claimed he was too busy campaigning to ...dailymail.co.uk - December 28 at 3:21 PMMetastatic Castration-Sensitive Prostate Cancer Market to Skyrocket at Astounding 22% CAGR During the Study Period (2019-2032), assesses DelveInsightfinance.yahoo.com - December 8 at 9:34 AMNCCN Announces Funding for Advanced Prostate Cancer Research Projectsmarkets.businessinsider.com - November 21 at 9:43 AMMyovant Sciences, Ltd. (MYOV) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoingsbarrons.com - October 22 at 10:14 AMSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Myovant Sciences, Ltd. - MYOVbenzinga.com - September 26 at 8:57 PM4D Molecular Therapeutics Appoints Uneek Mehra Finance & Business Chiefmarketwatch.com - September 12 at 6:07 PMVivek Ramaswamy claims he is too busy campaigning to give evidencemsn.com - August 29 at 1:24 AM2024 Presidential candidate Vivek Ramaswamy trying to duck legal battle over his biotech empiremsn.com - August 29 at 1:24 AMEXCLUSIVE: Vivek Ramaswamy claims he is too busy campaigning for President to give evidence in multi-million dollar court casemsn.com - August 28 at 8:23 PMVivek Ramaswamy cites campaign to duck deposition in buyout suitmsn.com - August 28 at 8:23 PMBill Ackman Tells Vivek Ramaswamy How To Run For Presidentmsn.com - August 24 at 9:44 PMUterine Fibroids Treatment Global Market Report 2023finance.yahoo.com - August 24 at 9:17 AMPresidential Hopeful Ramaswamy Predicts US Recession In 2024benzinga.com - August 21 at 6:34 PMHormone Therapy Global Market Report 2023uk.finance.yahoo.com - July 4 at 12:48 PMHealth in Her HUE to Host Discussion Around Fibroids Awareness and Launch the Fibroids-focused Care Squad Program during Fibroid Awareness Monthfinance.yahoo.com - June 26 at 12:41 PMAntibacterial Drugs Market to Reach US$ 62 Billion by 2031 | Fact.MR Reportbenzinga.com - June 22 at 11:46 PMWomen's Health Market to Reach $63.02 Billion by 2030: Grand View Research, Inc.finance.yahoo.com - May 18 at 7:00 AMMyovant Sciences and Evidation Announce Survey Results of Unseen Burdens at Work and School of Individuals with Endometriosis and/or Uterine Fibroidsfinance.yahoo.com - May 17 at 9:48 AMEndometriosis Treatment Drugs Market Top Competitors and Prediction Till 2030marketwatch.com - May 16 at 1:35 PMMetastatic Prostate Cancer Treatment Market Size: Growth Dynamics from 2023 to 2031marketwatch.com - May 10 at 9:50 AMMenstrual Cramps Treatment Market worth growing 4.0% at a CAGR by 2027marketwatch.com - May 8 at 10:45 PMGlobal "Metastatic Prostate Cancer Treatment Market" Growth and Outlook till 2023-2030marketwatch.com - May 8 at 5:45 PM8-K: Day One Biopharmaceuticals, Inc.marketwatch.com - May 2 at 8:33 AMProstate Cancer Treatment Market Business Expands Quickly and Will Occupy Over USD 12,152 Million by 2030marketwatch.com - April 27 at 11:02 AMEndometriosis Market Growth by 2031marketwatch.com - April 26 at 8:24 AMMyovant Sciences won 3 drug approvals and got bought out. Now it's cutting nearly 100 jobs.bizjournals.com - April 25 at 10:22 PMLeading National Prostate Cancer Nonprofit Announces Return of Annual Run/Walk Seriesfinance.yahoo.com - April 25 at 5:21 PMMyovant Sciences (NYSE:MYOV) Receives New Coverage from Analysts at StockNews.commarketbeat.com - April 11 at 1:24 AMSumitomo Pharma Subsidiary Companies in the U.S., Including Sumitovant and its Wholly Owned Subsidiaries, to Combine and Form Sumitomo Pharma Americafinance.yahoo.com - April 3 at 3:12 PMMyovant Sciences (NYSE:MYOV) Now Covered by Analysts at StockNews.commarketbeat.com - April 3 at 1:22 AMEndometriosis Global Market Report 2022: Rise in Demand for Novel Drugs and Hormonal Therapies Bolsters Sectorfinance.yahoo.com - March 29 at 7:44 AMEndometriosis Treatment Drugs Market Growth By 2031marketwatch.com - March 27 at 12:47 AMMyovant Sciences (NYSE:MYOV) Coverage Initiated at StockNews.commarketbeat.com - March 26 at 1:20 AMHennion & Walsh Asset Management Inc. Sells 141,504 Shares of Myovant Sciences Ltd. (NYSE:MYOV)marketbeat.com - March 21 at 7:14 AMMyovant Sciences (NYSE:MYOV) Now Covered by StockNews.commarketbeat.com - March 18 at 1:16 AMMyovant Sciences Ltd. (NYSE:MYOV) Major Shareholder Chemical Co. Ltd. Sumitomo Acquires 51,599,200 Sharesmarketbeat.com - March 10 at 10:20 AMGlobal GnRH Receptor Antagonists Market research Report with Analysis 2023 To 2028marketwatch.com - March 10 at 8:43 AMmarketbeat.com - March 10 at 8:14 AMAs a two-time CEO, Lynn Seely is putting more cracks in the glass ceilingbizjournals.com - March 3 at 2:13 PMMyovant Sciences Ltd. (NYSE:MYOV) Shares Acquired by ExodusPoint Capital Management LPmarketbeat.com - February 23 at 4:59 AMGlobal Uterine Fibroids Treatment Market Report to 2027: Players Include Myovant Sciences, Gynesonics, Medtronic and Boston Scientificfinance.yahoo.com - February 9 at 4:06 PMMyovant Sciences, Inc.: Myovant Sciences Announces Corporate Updates and Financial Results for Third Fiscal Quarter 2022finanznachrichten.de - January 29 at 3:43 PMMYOV Myovant Sciences Ltd.seekingalpha.com - January 26 at 8:46 PMInsider Selling: Myovant Sciences Ltd. (NYSE:MYOV) General Counsel Sells 1,272 Shares of Stockmarketbeat.com - January 20 at 6:25 PMCubist Systematic Strategies LLC Increases Holdings in Myovant Sciences Ltd. (NYSE:MYOV)marketbeat.com - January 20 at 12:26 PM Get Myovant Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for MYOV and its competitors with MarketBeat's FREE daily newsletter. Email Address Did You Get Your Free Bitcoin Yet? (Ad)And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin. >> Register right here MYOV Media Mentions By Week MYOV Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MYOV News Sentiment▼0.000.36▲Average Medical News Sentiment MYOV News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MYOV Articles This Week▼10▲MYOV Articles Average Week Get Myovant Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for MYOV and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: TGTX News CORT News MOR News BHC News MLTX News VERA News INDV News PTCT News RNA News RYTM News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:MYOV) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersThis 1 Biotech Stock has been shocking the marketsHuge Alerts1970’s computer coder Issues Shocking AI WarningInvestorPlaceThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldHe Is Giving Away BitcoinCrypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressGold Set to EXPLODE!Gold Safe ExchangeThe A.I. story nobody is telling you (Read ASAP)TradeSmithTrump Asset Seizure Threat Alert: Could Your Savings Be Next?American Hartford Gold Group Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Myovant Sciences Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
